Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04349267
Title Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications

lung non-small cell carcinoma

renal cell carcinoma

head and neck squamous cell carcinoma

Therapies

BMS-986315 + Cetuximab

BMS-986315

BMS-986315 + Nivolumab

Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Local Institution Withdrawn Baltimore Maryland 21287 United States Details
Sanford Clinic Clinical Research Recruiting Sioux Falls South Dakota 57104 United States Details
The West Clinic, P.C. Recruiting Germantown Tennessee 38138 United States Details
Local Institution Withdrawn Capital Federal Distrito Federal C1428 Argentina Details
Local Institution - 0011 Recruiting Vancouver British Columbia V5Z 4E6 Canada Details
Local Institution Withdrawn Vancouver British Columbia V5Z 4E6 Canada Details
Local Institution Withdrawn Ottawa Ontario K1H 8L6 Canada Details
Local Institution Recruiting Toronto Ontario M5G 1Z5 Canada Details
Local Institution Recruiting Montreal Quebec H2X 3E4 Canada Details
Local Institution - 0014 Recruiting Edmonton T6X 1E8 Canada Details
Local Institution - 0013 Recruiting Ottawa K1H 8L6 Canada Details
Local Institution Withdrawn Recoleta Metropolitana Chile Details
Local Institution Not yet recruiting Mexico city Distrito Federal 06100 Mexico Details
Local Institution Not yet recruiting Monterrey Nuevo LEON 64460 Mexico Details
Local Institution Not yet recruiting San Luis Potosi 78250 Mexico Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field